FIELD: biotechnology.
SUBSTANCE: invention relates to compounds of the formula (II), as well as pharmaceutical compositions based on them.
EFFECT: new compounds are obtained, which can be used as MAGL activity inhibitors.
7 cl, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
PYRAZOLE-BASED MAGL INHIBITORS | 2018 |
|
RU2789157C2 |
MAGL INHIBITORS | 2017 |
|
RU2754536C1 |
DIHYDROPTERIDINONE DERIVATIVES AND USES THEREOF | 2015 |
|
RU2673944C2 |
CYANOTHIENOTRIAZOLODIAZEPINES AND METHODS FOR THEIR USE | 2016 |
|
RU2750164C2 |
BIVALENT BROMODOMAIN INHIBITORS AND ROUTES OF USE THEREOF | 2016 |
|
RU2742035C2 |
HETEROCYCLIC SPIRO COMPOUNDS AS MAGL INHIBITORS | 2018 |
|
RU2726631C1 |
MATRIX METALLOPROTEINASE (MMP) INHIBITORS AND METHODS FOR THEIR APPLICATION | 2019 |
|
RU2820540C2 |
NEW INHIBITOR BASED ON A QUINOLINE DERIVATIVE | 2019 |
|
RU2802283C2 |
MATRIX METALLOPROTEINASE (MMP) INHIBITORS AND METHODS OF THEIR APPLICATION | 2019 |
|
RU2797558C2 |
3-(1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND VARIANTS OF THEIR USE | 2018 |
|
RU2795850C2 |
Authors
Dates
2022-10-17—Published
2018-08-28—Filed